Zachery R Reichert, Maha H. A. Hussain, Jennie L Lovett, Masha Kocherginsky, Channing Judith Paller, Neeraj Agarwal, Nabil Adra, Jingsong Zhang, Joel Picus, Russell Zelig Szmulewitz, Timothy M Kuzel, Scott T. Tagawa, Latifa A Bazzi, Young E. Whang, Ryan D. Stephenson, Robert Dreicer, Daniel Shevrin, Matthew Rettig, Emmanuel S. Antonarakis, Todd Matthew Morgan. "Circulating tumor cell expression analysis from the phase 2 trial of abiraterone, olaparib, or abiraterone + olaparib in first-line metastatic castration-resistant prostate cancer (mCRPC) with DNA repair defects (BRCAAway).." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.5_suppl.199